| Literature DB >> 26277554 |
Takato Takenouchi1, Mitsutoshi Tsukimoto2, Yoshifumi Iwamaru3, Shuei Sugama4, Kazunari Sekiyama5, Mitsuru Sato6, Shuji Kojima2, Makoto Hashimoto5, Hiroshi Kitani7.
Abstract
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is a key glycolytic enzyme that is predominantly localized in the cytoplasm. However, recent studies have suggested that GAPDH is released by various cells and that extracellular GAPDH is involved in the regulation of neuritogenesis in neuronal cells. It has also been reported that GAPDH is expressed on the surfaces of macrophages and functions as a transferrin receptor. However, since GAPDH is a leaderless protein the mechanisms by which it reaches the extracellular environment remain unclear. Here, we examined the role of P2X7 receptor (P2X7R), an ATP-gated cation channel, in the unconventional release of GAPDH from microglial cells, the resident macrophages in the brain. The activation of P2X7R by ATP triggered GAPDH release from lipopolysaccharide (LPS)-primed microglial cells. ATP-induced microvesicle formation, exosome release, and K(+) efflux followed by caspase-1 activation are likely involved in the GAPDH release, but ATP-induced dilatation of membrane pores and lysosome exocytosis are not. It was also demonstrated that exogenous GAPDH facilitated LPS-induced phosphorylation of p38 MAP kinase in microglial cells. These findings suggest that P2X7R plays an important role in the unconventional release of GAPDH from microglial cells, and the GAPDH released into the extracellular space might be involved in the regulation of the neuroinflammatory response in the brain.Entities:
Keywords: Glyceraldehyde-3-phosphate dehydrogenase; Microglial cells; P2X7 receptor; Unconventional release
Mesh:
Substances:
Year: 2015 PMID: 26277554 DOI: 10.1016/j.imlet.2015.08.002
Source DB: PubMed Journal: Immunol Lett ISSN: 0165-2478 Impact factor: 3.685